HLB Life Science Co., Ltd. (KOSDAQ:067630)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,860.00
+30.00 (0.51%)
Jun 5, 2025, 3:30 PM KST

HLB Life Science Revenue

HLB Life Science had revenue of 27.48B KRW in the quarter ending March 31, 2025, with 14.99% growth. This brings the company's revenue in the last twelve months to 105.82B, up 16.65% year-over-year. In the year 2024, HLB Life Science had annual revenue of 102.24B with 4.34% growth.

Revenue (ttm)
105.82B
Revenue Growth
+16.65%
P/S Ratio
6.75
Revenue / Employee
691.65M
Employees
153
Market Cap
714.02B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024102.24B4.25B4.34%
Dec 31, 202397.99B-1.60B-1.61%
Dec 31, 202299.59B46.10B86.17%
Dec 31, 202153.49B-38.30B-41.73%
Dec 31, 202091.80B-22.22B-19.49%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Korea Electric Power 94.33T
Korea Gas 38.31T
Korea District Heating 3,772.56B
SK eternix 419.70B
Samchully Co.,Ltd 5,179.01B
Korea Electric Power Industrial Development 370.02B
Seoul City Gas 1,769.53B
INVENI 1,207.41B
Revenue Rankings